Random Flashcards
What is the recommendation of the American Society of Echocardiography (ASE)/European Association of Cardiovascular Imaging (EACI) on the cardiac reassessment after anthracycline-based therapy?
reassessment of left ventricular ejection fraction (LVEF), global longitudinal strain (GLS), and cardiac troponin (cTn) at completion and at 6 months after anthracycline-based therapy, unless the cumulative dose is greater than 240 mg/m2 doxorubicin equivalents, in which case repeated measurements of LVEF, GLS, and cTn should be performed even during cancer therapy, before each additional 50 mg/m2 dose.
Recommendation for cardiac reassessment after doxorubicin therapy
Reassessment of cardiac function is to be done after a cumulative dose of 250 mg/m2 doxorubicin, each additional 100 mg/m2 thereafter, at the end of therapy, 6 to 12 months and 2 years thereafter.
